High-dose cytosine arabinoside and L-asparaginase in refractory acute lymphoblastic leukemia: The children's cancer group experience

Medical and Pediatric Oncology

Volumn 30, Issue 4, 1998, Pages 233-239

  Harris, R E ^a   Sather, H N ^a   Feig, S A ^a  

^a CHILDREN S ONCOLOGY GROUP   (United States)

Author keywords

Childhood ALL; Cytosine arabinoside; First relapse; L asparaginase

Indexed keywords

ASPARAGINASE; CYTARABINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BACTERIAL INFECTION; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CHILDHOOD LEUKEMIA; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MEGADOSE; ERYTHRODERMA; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MYCOSIS; NEUTROPENIA; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CHILD; CHILD, PRESCHOOL; CYTARABINE; FEMALE; HUMANS; INFECTION; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAMUSCULAR; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; PROGNOSIS; RECURRENCE; TREATMENT OUTCOME;

EID: 0031893722     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199804)30:4<233::AID-MPO5>3.0.CO;2-H     Document Type: Article

References (34)